OCON Therapeutics
Formerly Ocon Medical
Spherical Intrauterine Drug Delivery Platform
Startup A Health Tech & Life Sciences Est. 2011
🌐 WebsiteLinkedInCareers
Total Raised
$24.5M
A
Last Round
$10M
8 rounds
Investors
12
7 public
Team
6
11-50 employees
Confidence
100/100
News
21
articles
Patents
1
About
OCON Therapeutics innovates, develops, manufactures, and commercializes women's health products based on its proprietary and patented intrauterine ball (IUB) platform. Made from the super-elastic alloy nitinol, the IUB is an ideal carrier of multiple drugs to the uterus for treating a variety of conditions. In addition to its flagship product, the IUB Ballerine, OCON Therapeutics is developing a pipeline of products utilizing the IUB frame for indications including abnormal uterine bleeding, heavy menstrual bleeding, myomas and fibroids, and infertility.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical DevicesMedical Treatment & Therapeutics
Core Technology
Materials & SubstancesImplants
Target Customer
Healthcare & Life SciencesHealthcareProvidersPatientsCommerce & RetailDistribution ChannelsDistributorConsumersDemographics & FamilyWomen
Business Model
B2BB2C
Tags
femtechpreventionmedical-productsmedical-devicespregnancygynecologywomen-healthnon-invasivewomenpatientstreatments
Funding & Events
Oct 2017
Undisclosed Round Undisclosed
Chemo Group
May 2013
Undisclosed Round $1.5M
Aliment Capital, Docor International Management
Mar 2011
Seed $500K
Docor International Management
Jun 2024
A Round $10M
Rhia Ventures (Lead), Exerte Partners, Features Capital, Astia Angels
Jun 2020
Undisclosed Round $2M
Docor International Management, Pontifax
Jan 2016
Undisclosed Round $3M
Abu Dhabi Education Council, EBR
Jan 2014
Undisclosed Round $3M
RMI Partners, Docor International Management, Pontifax
Dec 2020
A Round $4.5M
Rhia Ventures (Lead), Pontifax (Lead), Astia Angels, Merchavia Holdings, Docor International Management
News (21)
Jul 16, 2024 · www.calcalistech.com
growth-positive
OCON Therapeutics raises $10 million for innovative IUD and women’s health solutions | CTech
InvestmentExpand
Jun 24, 2024 · www.finsmes.com
growth-positive
OCON Therapeutics Raises $10M in Funding
Investment
Jul 2, 2023 · www.calcalistech.com
growth-positive
OCON Therapeutics improving women's quality of life with innovative IUD design and targeted health solutions | CTech
CustomersInvestment
Jun 27, 2022 · www.prnewswire.com
growth-positive
Significant breakthrough: The FEMTECH company OCON Healthcare of the Merchavia Investments Group has signed an exclusive agreement with BioGenuine to market its products in China and Southeast Asian countries
Partners
Jun 12, 2022 · www.themarker.com
growth-positive
האם התקן תוך רחמי בצורת כדור ישנה את האופן שבו מטפלים בנשים?
InvestmentExpand
Jun 7, 2022 · www.calcalistech.com
growth-positive
Her body - not her choice: Technology's role in the face of government conservatism CTech
InvestmentExpand
May 11, 2022 · www.prnewswire.com
growth-positive
OCON Healthcare Awarded as Technology Pioneer by the World Economic Forum
Customers
May 16, 2021 · jewishbusinessnews.com
growth-positive
OCON Healthcare Develops New Women's Health Devices
InvestmentExpand
Apr 28, 2021 · femtechinsider.com
growth-positive
Frost & Sullivan Awards OCON Healthcare with the 2021 Global Enabling Technology Leadership Award
Customers
Mar 21, 2021 · www.globes.co.il
growth-positive
אוקון הלת' קר: תוצאות ניסוי טובות בטיפול בדימום חריג מהרחם
Investment
Feb 4, 2021 · seekingalpha.com
growth-positive
Dr. Robert Auerbach joins femtech startup OCON Healthcare's Board of Directors - retired President of CooperSurgical
Management Changes
Jan 27, 2021 · femtechinsider.com
growth-positive
OCON Healthcare Announces Positive Long-Term efficacy and safety data on over 100K users of its Smart IUB Ballerine Hormone-Free Contraceptive
CustomersPartnersInvestment
growth-positive
"COVID is a Great Teacher," Says Femtech Startup OCON Healthcare's CEO, Keren Leshem
Customers
Dec 21, 2020 · www.prnewswire.com
growth-positive
FemTech startup OCON Healthcare completes funding round and appoints Dr. Anula Jayasuriya to Chairwoman
InvestmentManagement Changes
Dec 18, 2020 · www.prnewswire.com
growth-positive
Rhia Ventures Invests in OCON Healthcare's Ballerine®, the first ever 3D spherical copper intrauterine contraceptive with a superior safety profile, a breakthrough in women's hormone-free birth control options
Investment
Aug 11, 2020 · www.calcalistech.com
growth-positive
Shani Gross-Eliyahu OCON, chief technology officer
Management Changes
Jul 13, 2020 · iglob.es
growth-positive
אוקון הלת'קר חתמה על הסכמי הפצה בהיקף 13 מיליון דולר
PartnersInvestmentExpand
Jul 8, 2020 · en.globes.co.il
growth-positive
FemTech co OCON Healthcare wins $13m intrauterine orders
CustomersPartners
Jun 17, 2020 · en.globes.co.il
growth-positive
OCON CEO promotes intrauterine innovation
Management Changes
Feb 17, 2018 · www.dailymail.co.uk
growth-positive
The pioneering contraceptive ball that could replace the coil
Customers
+ 1 more articles
Details
Product Stage
Released
Employees
11-50
Exact Count
34
Founded
2011
Registrar
514568328
Crunchbase
ocon-medical
Locations
HaMiktsoot Blvd 14, Modi'in-Maccabim-Re'ut, Israel
Herostrasse 12, 8048 Zrich, Switzerland
Links
Website
oconmed.com
LinkedIn
Profile
Facebook
Page
Careers
Open positions
Admin
Last Update
Jan 5, 2025
Verified by
Yanina Wainscheinker
Claimed
Yes
Missing
markets
Team (6)
Keren Leshem
CEO
Amir Avraham
CFO & GM
Prof. Sergio Haimovich
CMO
Daniela Schardinger
VP Marketing & Medical Affairs
Shani Ben Hur
Medical Affairs Director
Susanne Mair
International Sales
Finder · OCON Therapeutics · 2026